SCHEMBL5356384

SCHEMBL5356384

COc1cc2c(N3CCc4ccc(C(N)=O)cc4C3)ncnc2c(OC)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.53
RPS6KB1 P23443 2/20 0.53
AURKB Q96GD4 1/20 0.53
POLB P06746 1/20 0.45
SLC2A1 P11166 1/20 0.42
SLC2A2 P11168 1/20 0.42
SLC2A3 P11169 1/20 0.42
PDE5A O76074 2/20 0.41
KIT P10721 2/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPK1 P28482 3/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SCN9A Q15858 3/20 0.39
ABCB1 P08183 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ACHE P22303 1/20 0.37
BACE1 P56817 1/20 0.37
PDE1B Q01064 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5356255 0.85 AURKA (0.52) AURKARPS6KB1AURKBPOLBSLC2A1
SCHEMBL5791238 0.85 AURKA (0.49) AURKARPS6KB1AURKBPOLBSLC2A1
SCHEMBL14407966 0.83 MAPT (0.56) POLBPDE5AKDM4EMAPK1MAPT
SCHEMBL8012169 0.83 PDE5A (0.48) PDE5AKDM4EMAPK1MAPTNPSR1
SCHEMBL5358500 0.77 KDM4E (0.47) AURKARPS6KB1AURKBPDE5AKDM4E
SCHEMBL5356662 0.76 KDM4E (0.48) PDE5AKITKDM4EMAPK1MAPT
SCHEMBL4452785 0.76 AURKA (0.44) AURKARPS6KB1AURKBPDE5AKIT
SCHEMBL5356821 0.76 ACHE (0.53) KITACHEBACE1
SCHEMBL8374872 0.75 PDE5A (0.51) PDE5AKDM4EMAPTALDH1A1HSD17B10
SCHEMBL16112172 0.74 AURKA (0.46) AURKARPS6KB1AURKBKITKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268142-B2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline PFIZER INC. (US) 2007-09-11 US claimed
US-20050182079-A1 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline PFIZER INC 2005-08-18 US claimed
US-7268142-B2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline PFIZER INC. (US) 2007-09-11 US disclosed
US-20050182079-A1 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline PFIZER INC 2005-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182079-A1 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline PDE5A, PDE3A, PDE3B AURKA 2442/4885RPS6KB1 4346/4885AURKB 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.